CYP Still has plenty of legs from it's current SP/Mcap I agree. Eager to see where they are at in another year or two.
Health industry as a whole will be in for a good year IMO. Particularly Stem cells and Tech health.
MEB, CYP, IMU, PTX, etc.
- Forums
- Commodities
- Biotech 2017
Biotech 2017, page-2
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
RDN
RAIDEN RESOURCES LIMITED
Dusko Ljubojevic, MD
Dusko Ljubojevic
MD
SPONSORED BY The Market Online